Cardiac health management company Hello Heart scooped up $70 million in a Series D funding round led by growth equity firm Stripes.
Other participants include IVP, Resolute and BlueRun Ventures. The round comes nearly a year after the startup announced a $45 million Series C raise.
WHAT IT DOES
Hello Heart's program includes a wireless blood pressure cuff that connects to an app, keeping track...
A digital self-management program using an app and a connected monitor could help lower blood pressure and maintain those improvements long-term, according to a study published in JAMA Network Open.
The study used Hello Heart devices, and was funded by the company. Two of the study’s authors were also Hello Heart employees.
TOP-LINE DATA
After one year, researchers found median systolic blood...
A CVS Health service designed to help CVS Caremark pharmacy benefit management clients more easily roll out and manage third-party health products has added five new digital health offerings to its lineup.
The program – which has also seen a branding change from "Vendor Benefit Management" to "Point Solutions Management" – was first announced last June with only single participating vendor: Big...
Chronic disease management platform Hello Heart will now integrate with LifeScan OneTouch meters as part of its program for diabetes management.
The Redwood City, California-based company started out in hypertension, but has been expanding into diabetes for the past year. OneTouch meters, formerly owned by Johnson & Johnson, are the first of a handful of glucometer brands the company intends...
Hello Heart — maker of an app-driven platform designed to help employees manage hypertension, heart rate, and cardiovascular health — has announced the release of a new service for diabetes management.
Both the cardiovascular and diabetes services are housed within the larger Hello Heart app, explained CEO Maayan Cohen, a move that represent the company’s shifting approach from a single-disease...
Correction: This article previously mentioned strategic investors in MedoPad. The reference has been removed, as the companies in question were not actually investors.
A London hospital is the latest to put the Apple Watch to use within its walls, this time to improve medication management and adherence for cancer patients undergoing chemotherapy. According to a report from Wareable, King's...
Redwood, California-based health app maker Hello Heart has raised $1.3 million in a round led by Resolute Ventures with participation from angel investors including Waze CEO Noam Bardin, BlueRun ventures Co-founder John Malloy, and Facebook Product Director Ran Makavy.
“We set out to do one thing -- make it simple, painless, and even fun to track and understand your medical data," Hello Heart CEO...